This is further supported by the significant attenuation of IL-17 production by T cell re-stimulated splenocytes and the diminished expression of Rorgc (a TH17 transcription factor) in the spleens of tumor bearing Stat4−/− mice. The gene discussed is IL17A; the disease is neoplasm.